Usability and Utility of Human Immunodeficiency Virus Pre-exposure Prophylaxis Clinical Decision Support to Increase Knowledge and Pre-exposure Prophylaxis Initiations among Pediatric Providers

被引:3
|
作者
Chan, Carrie T. T. [1 ,2 ,3 ,8 ]
Carlson, Jennifer [4 ]
Lee, Tzielan [5 ]
Vo, Megen [4 ]
Nasr, Annette [1 ,2 ,6 ]
Hart-Cooper, Geoffrey [7 ]
机构
[1] Lucile Packard Childrens Hosp, Palo Alto, CA USA
[2] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[4] Stanford Univ, Dept Pediat Adolescent Med, Sch Med, Palo Alto, CA USA
[5] Stanford Univ, Dept Pediat Rheumatol, Sch Med, Palo Alto, CA USA
[6] Stanford Univ, Dept Pediat Gastroenterol, Sch Med, Palo Alto, CA USA
[7] Stanford Childrens Hlth, Menlo Pk, CA USA
[8] Stanford Childrens Hlth, 750 Welch Rd,Suite 212, Palo Alto, CA 94304 USA
来源
APPLIED CLINICAL INFORMATICS | 2022年 / 13卷 / 05期
关键词
clinical decision support; electronic health records; adolescent medicine; alert; order set; healthcare providers; pediatric health; PRIMARY-CARE; UNITED-STATES; HIV CARE; ALERT; PREP; PRESCRIPTION; IMPLEMENTATION; IMPROVE; ORDER; RATES;
D O I
10.1055/a-1975-4277
中图分类号
R-058 [];
学科分类号
摘要
Objectives An effective clinical decision support system (CDSS) may address the current provider training barrier to offering preexposure prophylaxis (PrEP) to youth at risk for human immunodeficiency virus (HIV) infection. This study evaluated change in provider knowledge and the likelihood to initiate PrEP after exposure to a PrEP CDSS. A secondary objective explored perceived provider utility of the CDSS and suggestions for improving CDSS effectiveness. Methods This was a prospective study using survey responses from a convenience sample of pediatric providers who launched the interruptive PrEP CDSS when ordering an HIV test. McNemar's test evaluated change in provider PrEP knowledge and likelihood to initiate PrEP. Qualitative responses on CDSS utility and suggested improvements were analyzed using framework analysis and were connected to quantitative analysis elements using the merge approach. Results Of the 73 invited providers, 43 had available outcome data and were included in the analysis. Prior to using the CDSS, 86% of participants had never been prescribed PrEP. Compared to before CDSS exposure, there were significant increases in the proportion of providers who were knowledgeable about PrEP ( p = 0.0001), likely to prescribe PrEP ( p < 0.0001) and likely to refer their patient for PrEP ( p < 0.0001). Suggestions for improving the CDSS included alternative "triggers " for the CDSS earlier in visit workflows, having a noninterruptive CDSS, additional provider educational materials, access to patient-facing PrEP materials, and additional CDSS support for adolescent confidentiality and navigating financial implications of PrEP. Conclusion Our findings suggest that an interruptive PrEP CDSS attached to HIV test orders can be an effective tool to increase knowledge and likelihood to initiate PrEP among pediatric providers. Continual improvement of the PrEP CDSS based on provider feedback is required to optimize usability, effectiveness, and adoption. A highly usable PrEP CDSS may be a powerful tool to close the gap in youth PrEP access and uptake.
引用
收藏
页码:1141 / 1150
页数:10
相关论文
共 50 条
  • [1] Pediatric Providers and Hiv Pre-exposure Prophylaxis
    Chenault, Kathryn
    Waddell, Jaylyn
    Tepper, Vicki
    [J]. PEDIATRICS, 2018, 141
  • [2] HUMAN IMMUNODEFICIENCY VIRUS PRE-EXPOSURE PROPHYLAXIS: IS IT THE ANSWER?
    Kwong, Jeffrey
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2015, 11 (01): : 14 - 14
  • [3] Pre-exposure Prophylaxis Against Human Immunodeficiency Virus
    Cinar, Gule
    Birengel, Serhat
    [J]. FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2018, 23 (01): : 1 - 7
  • [4] Preventing New Human Immunodeficiency Virus Infections With Pre-exposure Prophylaxis
    Cotler, Karen
    Yingling, Charles
    Broholm, Cindy
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (05): : 376 - 382
  • [5] Pre-Exposure Prophylaxis for Human Immunodeficiency Virus and Primary Health Care
    RODRIGUES, Bruna
    CUNHA, Maria Joao da
    [J]. ACTA MEDICA PORTUGUESA, 2022, 35 (7-8) : 604 - 604
  • [6] The Impact of Pre-exposure Prophylaxis for Human Immunodeficiency Virus on Gonorrhea Prevalence
    Pharaon, Joe
    Bauch, Chris T.
    [J]. BULLETIN OF MATHEMATICAL BIOLOGY, 2020, 82 (07)
  • [7] The Impact of Pre-exposure Prophylaxis for Human Immunodeficiency Virus on Gonorrhea Prevalence
    Joe Pharaon
    Chris T. Bauch
    [J]. Bulletin of Mathematical Biology, 2020, 82
  • [8] Pre-Exposure Prophylaxis as a Method for Prevention of Human Immunodeficiency Virus Infection
    Elbirt, Daniel
    Mahlab-Guri, Keren
    Bezalel-Rosenberg, Shira
    Asher, Ilan
    Sthoeger, Zev
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (05): : 294 - 298
  • [9] Pharmacists as providers of HIV pre-exposure prophylaxis
    Christine Bruno
    Parya Saberi
    [J]. International Journal of Clinical Pharmacy, 2012, 34 : 803 - 806
  • [10] Consensus statement on human immunodeficiency virus pre-exposure prophylaxis in China
    Xu, Jun-Jie
    Huang, Xiao-Jie
    Liu, Xin-Chao
    Wang, Li-Ming
    Chen, Yao-Kai
    Wang, Hui
    Zhang, Fu-Jie
    Wu, Hao
    Li, Tai-Sheng
    Han, Meng-Jie
    Zhao, Fang
    Ding, Hai-Bo
    Duan, Jun-Yi
    Sheng, Gen-Shen
    Shang, Hong
    [J]. CHINESE MEDICAL JOURNAL, 2020, 133 (23) : 2840 - 2846